Wolfgang Miesbach: How Clonal Hematopoiesis May Explain Age-Related Mitochondrial Mutations
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn about a recent article by Rahul Gupta et al, published in Nature, adding:
”Has the secret of aging been unlocked?
A groundbreaking Nature study analyzing 750,000 plus
genomes has revealed why our blood cells accumulate mitochondrial DNA mutations as we age—and the answer challenges decades of scientific thinking.
The two-step revelation:
Step 1: Mitochondrial DNA replication errors create low-level ‘cryptic’ mutations in our cells—think of them as hidden genetic typos that go unnoticed.
Step 2: Clonal hematopoiesis (CH) amplifies these mutations by expanding specific cell clones, making the previously invisible mutations detectable.
What makes this paradigm-shifting:
- NOT oxidative stress (the old theory) – Replication errors driving the process
- The mutations are neutral passengers, not drivers of disease—both functional and silent variants accumulate equally in CH carriers
- Clinical impact: Strong associations with myelodysplastic syndrome, leukemias, and chronic kidney disease
- Game-changer: mtDNA mutation burden could detect early CH before traditional screening identifies driver mutations
This elegant work connects three aging hallmarks—mitochondrial mutations, clonal hematopoiesis, and telomere biology—into one unified mechanism.
The implications for early detection and risk stratification in hematologic malignancies are profound.”
Title: Mechanism of age-related accumulation of mtDNA mutations in human blood
Authors: Rahul Gupta, Timothy J. Durham, Grant Chau, Masahiro Kanai, Md Mesbah Uddin, Wenhan Lu, M. Austin Argentieri, Konrad J. Karczewski, Daniel Howrigan, Pradeep Natarajan, Wei Zhou, Benjamin M. Neale, Vamsi K. Mootha

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 16:17Shailendra Singh: Bombay Hospital Jaipur Inaugurates New Facility with Voluntary Blood Donation Camp
-
Nov 13, 2026, 16:10Minka Zivkovic: UMC Utrecht Announces Research Analyst Vacancy in Thrombosis and Haemostasis
-
Nov 13, 2026, 16:02Rounak Dubey: Elsevier’s Upcoming Handbook Explores Digitalization in Transfusion Medicine
-
Nov 13, 2026, 15:50Maha Othman: CanVECTOR 2026 Highlights Research on Immunothrombosis and Cancer-Associated Thrombosis
-
Nov 13, 2026, 15:48Cedric Hermans: Advances in Gene Therapy for Haemophilia A
-
Nov 13, 2026, 15:45Strengthens Global Collaboration in Thrombosis and Hemostasis for 2027 – ISTH
-
Nov 13, 2026, 15:42David McIntosh: The Global Blood Shortage Crisis and the Urgent Need for National Action
-
Nov 13, 2026, 15:41JTH Highlights Future Directions in Thromboprophylaxis for Hospitalized Children
-
Nov 13, 2026, 15:21Wolfgang Miesbach։ Gene Therapy for Haemophilia B Is Cheaper Than Lifelong Factor IX Prophylaxis in Sweden